Alnylam Pharmaceuticals receives a prestigious "Tell Award" for business investment in Switzerland

Alnylam Pharmaceuticals, Inc., an American company at the forefront of innovation, today received the 2024 Tell Award from Ambassador Niculin Jaeger, Consul General of Switzerland, and Artur Czerniejewski, Director of the Swiss Business Hub USA, in a ceremony highlighting the close ties between Switzerland and the U.S. in innovation and investments.